OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0609$1.2556

Tiande Chemical Holdings Ltd

Commodity ChemicalsVerified

Tiande Chemical Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.14, indicating limited leverage. The company's liquidity position is characterized as medium, with a current ratio of 2.26, suggesting adequate short-term liquidity to cover obligations. However, the company's free cash flow of 21.08 million CNY is significantly lower than its operating cash flow of 277.93 million CNY, indicating capital expenditure outflows of 186.15 million CNY. Profitability metrics show a return on equity (ROE) of 2.56% and a return on assets (ROA) of 2.03%, both below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 12.20% (231.33 million CNY on 1.896 billion CNY revenue), and its operating margin is 3.83% (72.66 million CNY on 1.896 billion CNY revenue), which are modest compared to industry benchmarks. The company's revenue is concentrated in a few geographic markets, with disclosed distribution to China, India, the United States, and the United Kingdom. No segment-specific revenue breakdown is available, but the geographic concentration suggests exposure to regional demand fluctuations and trade policy shifts. Growth trajectory is constrained, with no specific revenue growth projections provided in the outlook. Historical revenue of 1.896 billion CNY reflects a stable but non-explosive performance. The company's valuation multiples, including a price-to-earnings ratio of 17.57 and an enterprise value-to-EBITDA ratio of 19.71, suggest a moderate valuation relative to earnings and cash flow. Risk factors include a medium liquidity rating and a negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution sources identified in the risk assessment. However, the negative net cash position may necessitate future financing, which could introduce dilution pressure. Recent events include the latest financial filing (HA-latest), which provides the most recent financial snapshot. No recent earnings call transcripts or material events are disclosed in the input data. The company's capital expenditure of 186.15 million CNY indicates ongoing investment in operations, but the outflow reduces free cash flow.

30-day price · 0609-0.05 (-3.8%)
Low$1.24High$1.40Close$1.26As of12 May, 00:00 UTC
Profile
CompanyTiande Chemical Holdings Ltd
Ticker0609.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Tiande Chemical Holdings Ltd is an investment holding company engaged in the research, development, manufacturing, and sales of fine chemical products, including cyanide derivatives, alcohol products, and chloroacetic acid derivatives, primarily distributed to China, India, the United States, and the United Kingdom.

Classification. Tiande Chemical Holdings Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Tiande Chemical Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.14, indicating limited leverage. The company's liquidity position is characterized as medium, with a current ratio of 2.26, suggesting adequate short-term liquidity to cover obligations. However, the company's free cash flow of 21.08 million CNY is significantly lower than its operating cash flow of 277.93 million CNY, indicating capital expenditure outflows of 186.15 million CNY. Profitability metrics show a return on equity (ROE) of 2.56% and a return on assets (ROA) of 2.03%, both below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 12.20% (231.33 million CNY on 1.896 billion CNY revenue), and its operating margin is 3.83% (72.66 million CNY on 1.896 billion CNY revenue), which are modest compared to industry benchmarks. The company's revenue is concentrated in a few geographic markets, with disclosed distribution to China, India, the United States, and the United Kingdom. No segment-specific revenue breakdown is available, but the geographic concentration suggests exposure to regional demand fluctuations and trade policy shifts. Growth trajectory is constrained, with no specific revenue growth projections provided in the outlook. Historical revenue of 1.896 billion CNY reflects a stable but non-explosive performance. The company's valuation multiples, including a price-to-earnings ratio of 17.57 and an enterprise value-to-EBITDA ratio of 19.71, suggest a moderate valuation relative to earnings and cash flow. Risk factors include a medium liquidity rating and a negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution sources identified in the risk assessment. However, the negative net cash position may necessitate future financing, which could introduce dilution pressure. Recent events include the latest financial filing (HA-latest), which provides the most recent financial snapshot. No recent earnings call transcripts or material events are disclosed in the input data. The company's capital expenditure of 186.15 million CNY indicates ongoing investment in operations, but the outflow reduces free cash flow.
Key takeaways
  • Tiande Chemical Holdings Ltd operates with a conservative capital structure and a debt-to-equity ratio of 0.14.
  • The company's ROE of 2.56% and ROA of 2.03% indicate modest profitability relative to industry benchmarks.
  • Revenue is concentrated in key markets, with no disclosed segment-specific breakdown.
  • Growth is limited, with no significant revenue growth projections and a moderate valuation multiple.
  • The company faces medium liquidity risk and a negative net cash position, which may require future financing.
  • No significant dilution sources are identified, but the negative net cash position could introduce dilution pressure.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.90B
Gross profit$231.3M
Operating income$72.7M
Net income$62.5M
R&D
SG&A
D&A
SBC
Operating cash flow$277.9M
CapEx-$186.1M
Free cash flow$21.1M
Total assets$3.09B
Total liabilities$647.9M
Total equity$2.44B
Cash & equivalents
Long-term debt$333.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.90B$72.7M$62.5M$21.1M
FY-1$1.87B$71.8M$66.9M-$71.8M
FY-2$2.08B$298.3M$211.1M-$135.5M
FY-3$3.52B$1.29B$870.9M$558.9M
FY-4$2.58B$542.7M$379.6M$282.9M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$3.09B$2.44B
FY-1$3.08B$2.42B
FY-2$2.92B$2.44B
FY-3$2.96B$2.41B
FY-4$2.32B$1.75B
PeriodOCFCapExFCFSBC
FY0$277.9M-$186.1M$21.1M
FY-1$395.4M-$199.8M-$71.8M
FY-2$649.2M-$318.5M-$135.5M
FY-3$854.8M-$285.0M$558.9M
FY-4$274.3M-$213.5M$282.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1.25
Market cap$1.10B
Enterprise value$1.43B
P/E17.6
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income19.7
EV/OCF5.2
P/B0.5
P/Tangible book0.5
Tangible book$2.44B
Net cash-$333.7M
Current ratio2.3
Debt/Equity0.1
ROA2.0%
ROE2.6%
Cash conversion4.5%
CapEx/Revenue-9.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric0609Activity
Op margin3.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin12.2%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-9.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity14.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 02:05 UTC#e82446f8
Market quoteclose CNY 1.25 · shares 0.88B diluted
no public URL
2026-05-12 02:05 UTC#a2149458
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 02:07 UTCJob: cedfdf8e